• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病中微伏级 T 波电交替的预后评估:9 年临床随访。

Prognostic Evaluation of Microvolt T-Wave Alternans in Hypertrophic Cardiomyopathy: 9-year Clinical Follow-up.

机构信息

Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil.

Universidade São Francisco, Bragança Paulista, SP - Brasil.

出版信息

Arq Bras Cardiol. 2023 Sep 4;120(8):e20220833. doi: 10.36660/abc.20220833. eCollection 2023.

DOI:10.36660/abc.20220833
PMID:37672406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10519242/
Abstract

BACKGROUND

Sudden cardiac death (SCD) resulting from ventricular arrhythmia is the main complication of hypertrophic cardiomyopathy (HCM). Microvolt T-wave alternans (MTWA) is associated with the occurrence of ventricular arrhythmias in several heart diseases, but its role in HCM remains uncertain.

OBJECTIVE

To evaluate the association of MTWA with the occurrence of SCD or potentially fatal ventricular arrhythmias in HCM patients in a long-term follow-up.

METHODS

Patients diagnosed with HCM and NYHA functional class I-II were consecutively selected. At the beginning of the follow-up, the participants performed the MTWA evaluation using the modified moving average during the stress test. The results were classified as altered or normal. The composite endpoint of SCD, ventricular fibrillation, sustained ventricular tachycardia (SVT) or appropriate implantable cardiac defibrillation (ICD) therapy was assessed. The level of significance was set at 5%.

RESULTS

A total of 132 patients (mean age of 39.5 ± 12.6 years) were recruited and followed for a mean of 9.5 years. The MTWA test was altered in 74 (56%) participants and normal in 58 (44%). Nine events (6.8%) occurred during the follow-up, with a prevalence of 1.0%/year - six SCDs, two appropriate ICD shocks and one episode of (SVT). Altered MTWA was associated with non-sustained ventricular tachycardia on Holter (p = 0.016), septal thickness ≥30 mm (p < 0.001) and inadequate blood pressure response to effort (p = 0.046). Five patients with altered MTWA (7%) and four patients with normal MTWA (7%) had the primary outcome [OR = 0.85 (95% CI: 0.21 - 3.35, p=0.83)]. Kaplan-Meir event curves showed no differences between normal and altered MTWA.

CONCLUSION

Altered MTWA was not associated with the occurrence of SCD or potentially fatal ventricular arrhythmias in HCM patients, and the low rate of these events during long-term follow-up suggests the good prognosis of this heart disease.

摘要

背景

由室性心律失常引起的心脏性猝死(SCD)是肥厚型心肌病(HCM)的主要并发症。微伏级 T 波交替(MTWA)与几种心脏病发生室性心律失常有关,但在 HCM 中的作用仍不确定。

目的

在长期随访中评估 MTWA 与 HCM 患者 SCD 或潜在致命性室性心律失常发生的相关性。

方法

连续选择诊断为 HCM 和 NYHA 心功能 I-II 级的患者。在随访开始时,参与者使用应激试验中的改良移动平均值进行 MTWA 评估。结果分为改变或正常。评估 SCD、心室颤动、持续性室性心动过速(SVT)或适当的植入式心脏除颤器(ICD)治疗的复合终点。显著性水平设定为 5%。

结果

共纳入 132 例患者(平均年龄 39.5 ± 12.6 岁),平均随访 9.5 年。74 例(56%)参与者的 MTWA 试验异常,58 例(44%)正常。随访期间发生 9 起事件(6.8%),发生率为 1.0%/年-6 例 SCD、2 例适当的 ICD 电击和 1 例(SVT)。MTWA 改变与 Holter 检查中非持续性室性心动过速(p=0.016)、室间隔厚度≥30mm(p<0.001)和运动时血压反应不足(p=0.046)相关。5 例 MTWA 改变的患者(7%)和 4 例 MTWA 正常的患者(7%)出现主要结局[OR=0.85(95%CI:0.21-3.35,p=0.83)]。Kaplan-Meier 事件曲线显示正常和改变的 MTWA 之间没有差异。

结论

在 HCM 患者中,MTWA 改变与 SCD 或潜在致命性室性心律失常的发生无关,长期随访中这些事件的发生率较低表明这种心脏病的预后良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7e/10519242/0072a6a43f21/0066-782X-abc-120-08-e20220833-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7e/10519242/2ab76aab3b22/0066-782X-abc-120-08-e20220833-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7e/10519242/0072a6a43f21/0066-782X-abc-120-08-e20220833-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7e/10519242/2ab76aab3b22/0066-782X-abc-120-08-e20220833-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7e/10519242/0072a6a43f21/0066-782X-abc-120-08-e20220833-gf01-en.jpg

相似文献

1
Prognostic Evaluation of Microvolt T-Wave Alternans in Hypertrophic Cardiomyopathy: 9-year Clinical Follow-up.肥厚型心肌病中微伏级 T 波电交替的预后评估:9 年临床随访。
Arq Bras Cardiol. 2023 Sep 4;120(8):e20220833. doi: 10.36660/abc.20220833. eCollection 2023.
2
Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者基于动态心电图的微小T波交替与5年心脏性猝死预测风险评分之间关系的评估。
Anatol J Cardiol. 2018 Sep;20(3):165-173. doi: 10.14744/AnatolJCardiol.2018.15945.
3
Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.微伏级 T 波电交替与自主神经系统参数有助于识别低心律失常风险的缺血性左心室收缩功能障碍患者。
PLoS One. 2018 May 3;13(5):e0196812. doi: 10.1371/journal.pone.0196812. eCollection 2018.
4
Intracardiac alternans compared to surface T-wave alternans as a predictor of ventricular arrhythmias in humans.与体表T波交替相比,心内交替作为人类室性心律失常预测指标的研究
Heart Rhythm. 2008 Jul;5(7):1003-8. doi: 10.1016/j.hrthm.2008.04.003. Epub 2008 Apr 4.
5
Evidence regarding clinical use of microvolt T-wave alternans.关于微伏级T波交替变化临床应用的证据。
Heart Rhythm. 2009 Mar;6(3 Suppl):S36-44. doi: 10.1016/j.hrthm.2008.10.011. Epub 2008 Oct 11.
6
Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.纽约心脏协会II级充血性心力衰竭患者微伏级T波电交替对猝死的预测意义:一项前瞻性研究。
Int J Cardiol. 2005 Oct 20;105(1):53-7. doi: 10.1016/j.ijcard.2004.12.026.
7
Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death.微伏 T 波电交替和电生理检查可预测不同的心律失常基质:对识别发生心源性猝死风险患者的意义。
Heart Rhythm. 2010 Jun;7(6):763-8. doi: 10.1016/j.hrthm.2010.02.012. Epub 2010 Feb 13.
8
Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death.微伏 T 波交替试验在识别高危或低危心源性猝死患者中的临床应用。
Heart Rhythm. 2012 Aug;9(8):1256-64.e2. doi: 10.1016/j.hrthm.2012.03.014. Epub 2012 Mar 8.
9
[Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].[微伏级T波电交替对心脏性猝死高危患者的预后价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Jun;36(6):517-22.
10
[Microvolt T wave alternans as a predictor for sudden cardiac death].[微伏级T波交替作为心脏性猝死的预测指标]
Nihon Rinsho. 2002 Jul;60(7):1324-33.

引用本文的文献

1
Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study.ACC/AHA和ESC心脏性猝死风险指南在不同肥厚型心肌病队列中的验证:分层肥厚型心肌病研究
Glob Heart. 2024 Dec 17;19(1):94. doi: 10.5334/gh.1380. eCollection 2024.
2
T-Wave Microalternans in Hypertrophic Cardiomyopathy: The Complexity of an Inherited Cardiac Condition with Multiple Phenotypic Expressions.肥厚型心肌病中的T波微交替:一种具有多种表型表达的遗传性心脏疾病的复杂性
Arq Bras Cardiol. 2023 Oct;120(8):e20230615. doi: 10.36660/abc.20230615.

本文引用的文献

1
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.肥厚型心肌病患者的风险分层和猝死预防的演变:植入式心脏复律除颤器的 20 年应用经验。
Heart Rhythm. 2021 Jun;18(6):1012-1023. doi: 10.1016/j.hrthm.2021.01.019. Epub 2021 Jan 26.
2
Hypertrophic Cardiomyopathy: A Review.肥厚型心肌病:综述。
Arq Bras Cardiol. 2020 Nov;115(5):927-935. doi: 10.36660/abc.20190802.
3
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
4
The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.钆延迟增强的程度优于当前指南推荐标准,可用于识别肥厚型心肌病患者中存在心源性猝死风险的患者。
J Cardiovasc Magn Reson. 2019 Aug 15;21(1):50. doi: 10.1186/s12968-019-0561-4.
5
Prevention of Sudden Death in Hypertrophic Cardiomyopathy.肥厚型心肌病猝死的预防
Arq Bras Cardiol. 2018 Jun;110(6):532-533. doi: 10.5935/abc.20180101.
6
Clinical Course and Management of Hypertrophic Cardiomyopathy.肥厚型心肌病的临床病程与管理
N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.
7
Exercise-induced quantitative microvolt T-wave alternans in hypertrophic cardiomyopathy.肥厚型心肌病中运动诱发的定量微伏T波交替变化
J Electrocardiol. 2017 Mar-Apr;50(2):184-190. doi: 10.1016/j.jelectrocard.2016.10.010. Epub 2016 Oct 28.
8
Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.肥厚型心肌病猝死的预防:弥合知识差距。
Eur Heart J. 2017 Jun 7;38(22):1728-1737. doi: 10.1093/eurheartj/ehw268.
9
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
10
Hypertrophic cardiomyopathy.肥厚型心肌病。
Lancet. 2013 Jan 19;381(9862):242-55. doi: 10.1016/S0140-6736(12)60397-3. Epub 2012 Aug 6.